Physical and Cognitive Exercises in Nursing Homes: Is Frailty Reversible?

November 20, 2019 updated by: Dominique Hansen, Hasselt University

Elderly in residential care spend 97% of their time sedentary. Moreover, exercise therapy often takes place in a poorly stimulating environment which is less motivational for the elderly to undertake regularly. Exercise is however necessary to preserve their physical capabilities and to limit their care dependence.

The aim of this study is to investigate the most motivating and stimulating exercise modality for prefrail and frail elderly in nursing homes with which they can reach sufficient training volume.

To study this, elderly will exercise in 3 different ways on an ergometer or motomed (according to their physical capabilities): 1) in an environment without other visual stimuli 2) in front of a television with National Geographic images 3) with the interactive software program MemoRide with which participants can exercise in real life on a virtual manner.

MemoRide (Activ84Health) uses Google Street View images. The starting point is a connection between an exercise bike and a tablet with a pedalling sensor. This way, pedal frequency is sent to the tablet and as a result, images continue when pedalling.

The forth modality is the control modality, in which participants are instructed to rest (supine) during 30 minutes.

Based on objective training parameters and metabolic parameters e.g. glucose, insulin, brain-derived neurotrophic factor (BDNF) and lactate, (via a blood sample with a venous catheter) the training modality which offers the best training results will be studied. Secondly, also subject experiences (motivation and emotions) will be evaluated by using questionnaires and observation scales.

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hasselt, Belgium, 3500
        • WZC Begralim (Campus Sint-Elisabeth)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women with an age of at least 70 years at the start of the study;
  • Staying for at least one month in WZC St. Elisabeth Hasselt at the start of the study;
  • Being frail or prefrail (according to the criteria of Fried);
  • Being available to participate in the study during 4 consecutive weeks;
  • Being able to actively exercise on an exercise bike (if necessary from a wheelchair) during at least 5 minutes;
  • Understand simple instructions.

Exclusion Criteria:

  • Any neurological or orthopedic disease which makes it impossible to exercise by bike actively e.g. stroke with hemiparesis of the lower limbs, amputations of the lower limbs,…;
  • Any disease which makes it impossible to exercise actively e.g. heart failure;
  • Any neurological or orthopedic disease from which progression (e.g. hip prosthesis, acute stroke) due to active recovery or decline (e.g. ALS (amyotropic lateral sclerosis), MS) due to the disease process can be expected on short term (1-2 months);
  • Being blind or visually impaired;
  • Any acute disease on the moment of the intervention which makes it impossible to exercise by bike during 30 minutes (e.g. hyper- or hypoglycemia) (reported by the caregiver)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Intervention 1
exercise on an ergometer or motomed in an environment without other visual stimuli
exercise on an ergometer or motomed in an environment without other visual stimuli
Other: Intervention 2
exercise on an ergometer or motomed while watching the National Geografics channel on television
exercise on an ergometer or motomed while watching the National Geografics channel on television
Other: Intervention 3
exercise on an ergometer or motomed with the interactive software program MemoRide with which participants can exercise in real life on a virtual manner
excercise on an ergometer or motomed with the interactive software program MemoRide with which participants can exercise in real life on a virtual manner
No Intervention: Control group
Rest during 30 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain Derived Neurotrophic Factor (BDNF)
Time Frame: Baseline
a protein produced inside the brain which can be transported outside the brain - it probably has a protective effect on neuronal survival and maintenance during adulthood
Baseline
Brain Derived Neurotrophic Factor (BDNF)
Time Frame: minute 30
a protein produced inside the brain which can be transported outside the brain - it probably has a protective effect on neuronal survival and maintenance during adulthood
minute 30
Distance immediately post-intervention
Time Frame: minute 30
evaluation of distance via data on the exercise bike
minute 30
Velocity
Time Frame: minute 30
evaluation of velocity via data on the exercise bike and pedalling sensor
minute 30
Intrinsic Motivation Inventory
Time Frame: minute 30
evaluation of motivation via Intrinsic Motivation Inventory questionaire
minute 30
Observed Emotion Rating Scale
Time Frame: minute 30
evaluation of emotions via an observation scale (Observed Emotion Rating Scale)
minute 30
Fatigue
Time Frame: minute 30
evaluation of perceived exertion via the BORG-scale
minute 30
Credibility-Expectancy Questionnaire
Time Frame: minute 30
evaluation of motivation via Credibility-Expectancy Questionnaire
minute 30

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose
Time Frame: baseline
Evaluation of glucose via a blood sample
baseline
Glucose
Time Frame: minute 30
Evaluation of glucose via a blood sample
minute 30
Insulin
Time Frame: baseline
Evaluation of insulin via a blood sample
baseline
Insulin
Time Frame: minute 30
Evaluation of insulin via a blood sample
minute 30
Heart rate
Time Frame: baseline
Evaluation of heart rate via a heart rate monitor
baseline
Heart rate
Time Frame: minute 30
Evaluation of heart rate via a heart rate monitor
minute 30
systolic and diastolic blood pressure
Time Frame: baseline
Evaluation of blood pressure via a blood pressure monitor
baseline
systolic and diastolic blood pressure
Time Frame: minute 30
Evaluation of blood pressure via a blood pressure monitor
minute 30
Lactate
Time Frame: minute 30
Evaluation of lactate via a finger prick
minute 30
depressed feelings
Time Frame: baseline
Evaluation of depressed feelings via a questionnaire (Geriatric Depression Scale)
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Nastasia Marinus, drs., Hasselt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

April 21, 2018

First Submitted That Met QC Criteria

May 15, 2018

First Posted (Actual)

May 16, 2018

Study Record Updates

Last Update Posted (Actual)

November 21, 2019

Last Update Submitted That Met QC Criteria

November 20, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PAIE-001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe